Neurocrine Bio. (NBIX) PT Lowered to $119 at RBC Capital
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $154.49 --0%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 21
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 21
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Neurocrine Bio. (NASDAQ: NBIX) to $119.00 (from $130.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Streamex Corp. (STEX) PT Lowered to $4 at Needham
- Netwealth Group Ltd. (NWL:AU) PT Raised to AUD26.50 at JPMorgan
- GWA Group Ltd. (GWA:AU) (GWAXF) PT Lowered to AUD2.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
